← Research library
ResearchModerate evidence

10 Hz binaural beats in opioid rehabilitation: a small sham-controlled trial with very large reported effects

Soleimanifar and Mansouriyeh (2026) · Research Square · Summary by Sentiosonics research agent
Year
2026
Stimulus
Alpha
Design
Two-arm randomized sham-controlled trial, pretest and posttest, participants and outcome assessor blinded
Sample
n = 30

Summary

Anxiety and aggression are common in opioid rehabilitation and both make relapse more likely, so a cheap non-drug add-on is worth testing. Soleimanifar and Mansouriyeh randomised 30 men in a residential treatment centre in Tabriz, Iran, to either ten 30-minute sessions of alpha-band binaural beats over three to four weeks, or the same ten sessions of an acoustically comparable audio track with no beats in it. The beat was 10 Hz, produced by a 440 Hz tone in the left ear and 450 Hz in the right, generated with the open-source Gnaural software.

The trial is better built than most in this field. The sham was matched for equipment, room, session length, schedule and researcher contact, so participants could not tell which arm they were in. Allocation was concealed, the outcome assessor was blinded, the primary outcome (the Beck Anxiety Inventory) was named in advance, and nobody dropped out.

The reported results are very large. Anxiety in the beat group fell from a mean of 29.1 to 12.0 while the sham group barely moved, 23.7 to 22.9. Total aggression on the Buss-Perry questionnaire fell from 107.1 to 79.5 against 100.3 to 98.6 in the sham group. After adjusting for baseline scores the group effect was significant for anxiety and for all four aggression subscales, with partial eta-squared values between 0.44 and 0.81. No adverse events were reported.

Those effect sizes are the problem. A partial eta-squared of 0.75 means three quarters of the remaining variance in post-treatment anxiety is attributed to which audio track a participant heard, which is larger than psychotherapy achieves and far larger than the pooled estimates in binaural beat meta-analyses. With 15 people per arm, an effect that extreme is more easily explained by chance, by the sham group’s floor (its anxiety started about five points lower and had less room to fall), or by the single unblinded person in the room, than by auditory entrainment.

Limitations. Thirty participants, one centre, men only, no follow-up after the last session, and both outcomes self-reported by people who knew they were in a study about sound. The trial was registered retrospectively, in January 2026, which removes the main protection against selective reporting. It is a preprint and has not been through peer review, which is why the rubric scores the venue low even though the design scores high. We grade it moderate on method and would treat the size of the effect as unconfirmed until a larger, prospectively registered trial reproduces it.

Our analysis

How we graded this study

Each criterion is scored 1–5. Study design and replication count double in the overall score (how we grade). Graded from: full text read.

Study designRandomized, parallel-group, sham-controlled trial with a predefined primary outcome and allocation concealment.
Sample size30 men, 15 per arm, all completed.
Control conditionAcoustically comparable sham audio without embedded beats, matched for equipment, schedule, setting and contact time.
BlindingParticipants and the outcome assessor were blinded; the person delivering the audio was not, and both outcomes are self-report.
Outcome measureBeck Anxiety Inventory (primary) and Buss-Perry Aggression Questionnaire, both validated, in Persian versions.
ReplicationFirst trial of this protocol in this population; no replication.
Conflicts of interestNo competing interests reported; university setting, no commercial sponsor.
Peer review & venueResearch Square preprint, not yet peer reviewed. Trial registered retrospectively with the Iranian Registry of Clinical Trials (IRCT20251206068230N1).
Overall grade · 3.7 / 5Moderate evidence

Graded by our research agent on Oct 14, 2026. Reviewed by the editor on Oct 14, 2026.

Get updates from the field

A monthly letter: new research, graded, and the claims worth checking. No hype.

Monthly, one click to unsubscribe. See our privacy policy.